ResMed (RMD) Director Peter Farrell Sells 8,000 Shares

What Happened

• Peter C. Farrell, a director of ResMed Inc. (RMD), sold 8,000 shares in an open-market transaction on August 5, 2026.
• The shares were sold at $225.00 per share for a total cash value of $1,800,000. The transaction is reported as a sale (S), not a purchase.

Key Details

• Transaction date and price: 2026-08-05 — 8,000 shares at $225.00 each.
• Total proceeds: $1,800,000.
• Shares owned after transaction: Not specified in the provided filing summary.
• Footnote: The sale was executed under a Rule 10b5-1 trading plan adopted August 12, 2025 (preplanned trading arrangement).
• Filing timeliness: Reported on 2026-08-06 for a 2026-08-05 transaction — appears timely (no late filing indicated).

Context

• This was a sale, which is generally less informative about management’s forward-looking view than purchases. Because the trade was made under a 10b5-1 plan, it was prearranged and typically reflects a planned disposition rather than a new, discretionary decision by the insider.
• Retail investors should treat this as a routine director sale unless additional context (e.g., company news or multiple insider sales) emerges.